July 03, 2019
1 min watch
Save
VIDEO: Surface Pharmaceuticals thrives in OCTANe environment
NEWPORT BEACH, Calif. — At OCTANe’s Ophthalmology Technology Summit, Kamran Hosseini, CEO of Surface Pharmaceuticals, discusses how the company has been working with OCTANe and the Visionary Venture Fund in developing its products for anterior segment surgery.